We previously revealed that FLT3-ITD activates the mTORC1/S6K/4EBP1 pathway cooperatively through the STAT5/PIM and PI3K/AKT pathways to enhance proliferation and survival of AML cells [12,13], which was extended in the present study by revealing that the MEK/ERK/RSK pathway also works cooperatively with these pathways. The gene discussed is MAP2K7; the disease is acute myeloid leukemia.